Drug Patent Expirations in August 2010

Drug Patent Expirations in August 2010

Tradename Applicant Generic Name Patent Number Patent Expiration
ATRIPLA Gilead efavirenz; emtricitabine; tenofovir disoproxil fumarate 7,402,588*PED Aug 1, 2010
TRUVADA Gilead emtricitabine; tenofovir disoproxil fumarate 7,402,588*PED Aug 1, 2010
EMTRIVA Gilead emtricitabine 7,402,588*PED Aug 1, 2010
GENESA Gensia Automedics arbutamine hydrochloride 5,234,404 Aug 10, 2010
PREVPAC Takeda Pharms Na amoxicillin; clarithromycin; lansoprazole 5,013,743*PED Aug 12, 2010
PREVACID Takeda Pharms Na lansoprazole 5,013,743*PED Aug 12, 2010
HECTOROL Genzyme doxercalciferol 5,707,980 Aug 17, 2010
NICORETTE Glaxosmithkline Cons nicotine polacrilex 5,110,605 Aug 21, 2010
COMMIT Glaxosmithkline Cons nicotine polacrilex 5,110,605 Aug 21, 2010
ZANTAC 300 Glaxosmithkline ranitidine hydrochloride 5,028,432*PED Aug 22, 2010
ZANTAC 150 Glaxosmithkline ranitidine hydrochloride 5,028,432*PED Aug 22, 2010
CAPOTEN Par Pharm captopril 5,238,924 Aug 24, 2010
COVERA-HS Gd Searle Llc verapamil hydrochloride 5,232,705 Aug 31, 2010

*Drugs may be covered by multiple patents

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com


Leave a Reply